William G Kaelin

22PUBLICATIONS
167CO-AUTHORS
Biologically active moleculesCancer therapy (excl. chemotherapy and radiation therapy)GravimetricsMolecular targetsStatistical mechanics in chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Sep 25, 2026
Positive selection screen identifies natural product β-catenin inactivators.

|Aug 05, 2026
Vorasidenib improves response to subsequent chemoradiation in a genetically engineered mouse model of IDH-mutant glioma.

|Jul 22, 2026
Oncogenic Gα signaling requires AP-3-dependent recruitment to the endolysosomal compartment.

|Nov 29, 2025
Targeting of HIF2-driven cachexia in kidney cancer.

Muhannad Abu-Remaileh, Laura A Stransky, Nikita Bhalerao

|Nov 14, 2025
The SLC1A1/EAAT3 dicarboxylic amino acid transporter is an epigenetically dysregulated nutrient carrier that sustains oncogenic metabolic programs.

Treg Grubb, Pooneh Koochaki, Sayed Matar

|Sep 18, 2025
HIF2-driven PTHrP Causes Cachexia and Hypercalcemia in Kidney Cancer: Treatment with HIF2 Inhibitors.

Muhannad Abu-Remaileh, Laura A Stransky, Nikita Bhalerao

Pageof 4

Frequent Collaborators

5 joint publications

Toni K Choueiri

4 joint publications

Marc Machaalani

4 joint publications

Muhannad Abu-Remaileh

4 joint publications

Sabina Signoretti